Lumanity

Lumanity

Lumanity was formed to address the critical inflection points in a medicine's path from discovery to patient access. The firm operates as a strategic services partner rather than an asset manager, employing over 1,200 experts who collaborate with nearly all top biopharma companies and more than 100 biotech firms globally (per the firm). Its founding date and principal operators are not publicly disclosed. The firm's capabilities span four domains: strategy, evidence generation, engagement, and technology and AI. In practice, Lumanity helps clients navigate pricing negotiations under the Inflation Reduction Act, build cell and gene therapy businesses from scratch, and craft go-to-market strategies for advanced therapies. Case studies highlight partnerships with a leading pharmaceutical manufacturer on Medicare drug price negotiations and with the world's largest pharmaceutical distributor on cell and gene therapy business creation. The firm's geographical footprint covers North America, Europe, and Asia, with offices in Morristown (NJ), Boston, New York, London, Sheffield, Farnham, Edinburgh, Grünwald, Nuremberg, Rotkreuz, Utrecht, and Gurugram. Lumanity employs 1,200 professionals across its global offices (per the firm). The firm also operates affiliated brands including Leith, Stripe Communications, and PHARMO. No recent operational event (within 24 months) has been publicly captured. Lumanity's structural differentiator is its proprietary Red Thread Planning™ philosophy, which integrates environmental changes and customer insights into strategic plans. This methodology, combined with a multidisciplinary team spanning strategy, evidence, engagement, and technology, allows Lumanity to address market complexities from initial strategy to market execution — a full-service model that competitors rarely match.